The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Lubnin A.Yu.

Burdenko Neurosurgical Center

Usachev D.Yu.

Burdenko Neurosurgical Center

Kurbasov A.A.

Burdenko Center of Neurosurgery

Shmigelsky A.V.

Burdenko Center of Neurosurgery

Gvazava G.I.

Burdenko Center of Neurosurgery

Tarasova N.Yu.

Burdenko Neurosurgical Center

Local application of recombinant activated factor VII for massive surgical bleeding

Authors:

Lubnin A.Yu., Usachev D.Yu., Kurbasov A.A., Shmigelsky A.V., Gvazava G.I., Tarasova N.Yu.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2021;85(3): 78‑83

DOI: 10.17116/neiro20218503178

Read: 2689 times

Download PDF (RU)
Download PDF
Contact the author
Table of contents

LOCAL APPLICATION OF RECOMBINANT ACTIVATED FACTOR VII FOR MASSIVE SURGICAL BLEEDING
LOCAL APPLICATION OF RECOMBINANT ACTIVATED FACTOR VII FOR MASSIVE SURGICAL BLEEDING

To cite this article:

Lubnin AYu, Usachev DYu, Kurbasov AA, Shmigelsky AV, Gvazava GI, Tarasova NYu. Local application of recombinant activated factor VII for massive surgical bleeding. Burdenko's Journal of Neurosurgery. 2021;85(3):78‑83. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20218503178

Подписка 2025 Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко (Burdenko's Journal of Neurosurgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
HARDI-CSD tractography in dete­rmining the stru­cture of diencephalic pathways in craniopharyngiomas. Burdenko's Journal of Neurosurgery. 2025;(1):30-36
Anatomical variants of papi­llary craniopharyngiomas: analysis of surgical series. Burdenko's Journal of Neurosurgery. 2025;(4):18-29
Radiosurgery for neurosurgical diseases (by the 20th anni­versary of neuroradiosurgery in Russia). Burdenko's Journal of Neurosurgery. 2025;(6):7-15
Anatomical and surgical research in neurosurgery. Traditions and trends. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(1):56-65
Pathology features of recu­rrent meni­ngioma. Russian Journal of Archive of Pathology. 2025;(5):28-35
Abstract:

The authors report resection of anaplastic convexital meningioma in a middle-aged woman complicated by expected massive blood loss. The most intense bleeding occurred at the final stage of resection and it was impossible to stop it with traditional approaches. The surgeon pressed a standard tachocomb plate moistened with a diluted solution of recombinant activated factor VII (coagil, Russia) to the most bleeding area for 5 minutes. Subsequently, surgeon replaced finger pressure with a permanent napkin. Hemostatic effect of recombinant activated factor VII following its systemic administration is well known and convincingly proven in many surgical areas including neurosurgery. However, we do not know any descriptions of its local application in neurosurgical patients.

Keywords:

neurosurgery
massive surgical blood loss
recombinant activated factor VII
local use of hemostatic agents

Authors:

Lubnin A.Yu.

Burdenko Neurosurgical Center

Usachev D.Yu.

Burdenko Neurosurgical Center

Kurbasov A.A.

Burdenko Center of Neurosurgery

Shmigelsky A.V.

Burdenko Center of Neurosurgery

Gvazava G.I.

Burdenko Center of Neurosurgery

Tarasova N.Yu.

Burdenko Neurosurgical Center

Received:

14.10.2020

Accepted:

19.03.2021

Close metadata

References:

  1. Lubnin AYu, Gromova VV. The problem of surgical blood loss and the use of modern blood-saving techniques in neurosurgery. Anesteziologiya i reanimatologiya. 2003;3:23-30. (In Russ.).
  2. Feng H, Charchaflieh JG, Wang T, Meng L. Transfusion in adult and children undergoing neurosurgery: the outcome evidence. Current Opinion in Anaesthesiology. 2019;32(5):574-579.  https://doi.org/10.1097/ACO.0000000000000754
  3. Muirhead B, Weiss ADH. Massive hemorrhage and transfusion in operating room. Canadian Journal of Anaesthesia. 2017;64(9):962-978.  https://doi.org/10.1007/s12630-017-0925-x
  4. O’Brien KL, Schainker SA, Lokhart EL. Transfusion management of obstetric hemorrhage. Transfusion Medicine Reviews. 2018;32(4):249-255.  https://doi.org/10.1016/j.tmrv.2018.05.003
  5. Roy S, Bigcas Jo-L, Vandelaar L. Hemostasis in pediatric surgery. Otolaryngologic Clinics of North America. 2016;49(3):601-614.  https://doi.org/10.1016/j.otc.2016.03.007
  6. Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Ruprow MFT, Hammond J. Impact of bleeding-related compliications and/or blood product transfusion on hospital costs in inpatient surgical patients. BMC Health Services Research. 2011;11:135.  https://doi.org/10.1186/1472-6963-11-135
  7. Sileshi B, Achnek HE, Ma L, Lauson JH. Application of energy-based technologies and topical hemostatic agents in the management of surgical hemostasis. Vascular. 2010;18(4):197-204.  https://doi.org/10.2310/6670.2010.00015
  8. Riaz O, Aqil A, Asmar S, Vanker R, Habnel J, Brew C, Grogan R, Radcliffe G. Epsilon-aminocapronic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study. Journal of Orthopaedics and Traumatology. 2019;20(1):28.  https://doi.org/10.1186/s10195-019-0534-2
  9. Karimi S, Lu VM, Nambiar M, Phan K, Ambikaipalan A, Mobbs RJ. Antifibrinolitic agents for paediatric scoliosis surgery: a systematic review and meta-analysis. European Spine Journal. 2019;28(5):1023-1034. https://doi.org/10.1007/s00586-019-05911-8
  10. Bar-Natan M, Hymes KB. Management of intraoperative coagulopathy. Neurosurgery Clinics of North America. 2018;29(4):557-565.  https://doi.org/10.1016/j.nec.2018.06.007
  11. Gerald AG. Update on hemostasis: Neurosurgery. Surgery. 2007;142(4):55-60.  https://doi.org/10.1016/j.surg.2007.06.030
  12. Zou JJ, Cluen J, Nakaji P. Intraoperative blood and coagulation factor replacement during neurosurgery. Neurosurgery Clinics of North America. 2018;29(4):547-555.  https://doi.org/10.1016/j.nec.2018.06.006
  13. Pereira BM, Bortoto JB, Fraga GP. Topical hemostatic agents in surgery: review and prospects. Revista do Colegio Brasileiro de Cirurgioes. 2018;45(5):e1900. https://doi.org/10.1590/0100-6991e-20181900
  14. Arendt AA, Bryusova SS. Methods and techniques of hemostasis in neurosurgery. Voprosy neirokhirurgii imeni N.N. Burdenko. 1949;13(1):3-18. (In Russ.).
  15. Abel T, Zanaty M, Walsh T, Howard MAIII. From Russian refuge to Jova’s first neurosurgeons and pioneer of cranial hemostasis: The legacy Anatole Kolodny (1892—1948). Neurosugery. 2017;80(1):159-164.  https://doi.org/10.1093/neuros/nyw007
  16. Sileshi B, Achnek HE, Lauson JH. Management of surgical hemostasis: topical agents. Vascular. 2008;16(1):522-528.  https://doi.org/10.2310/6670.2008.1.00030
  17. Shivukula S, Weiner GM, Engh JA. The early days of hemostasis in neurosurgery. Neurosurgical Focus. 2014;36(4):E5.  https://doi.org/10.3171/2014.FOCUS13565
  18. Kimpton G, Dabbous B, Leach P. New oral anticoagulants and antiplatelet agents for neurosurgeons. British Journal of Neurosurgery. 2015;29(5):614-621.  https://doi.org/10.3109/02688697.2015.1029433
  19. Rahwan A, Latona J. New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents. Australian Family Physician. 2014;43(12):861-866. 
  20. Vakharia VM, Tai D, Marcus H, Vakharia NN, Nandi D. New oral anticoagulants: Implications for neurosurgery. British Journal of Neurosurgery. 2015;29(2):182-188.  https://doi.org/10.3109/0268869.2014.997667
  21. Lubnin AYu. The use of activated recombinant factor VII in neurosurgery. Voprosy nejrokhirurgii imeni N.N. Burdenko. 2018;82(2):112-118 (in Russ.). https://doi.org/10.17116/oftalma201882112-119
  22. Kyang LS, Howard A, Alzahrani NA, Morris DL. Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use local hemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rVIIa). International Journal of Surgery Case Reports. 2019;57:48-51.  https://doi.org/10.1016/j.ijscr.02.042
  23. Samudral S. Topical hemostatic agents in surgery: a surgeon’s perspective. AORN Journal. 2008;88(3):2-11.  https://doi.org/10.1016/S0001-2092(08)00-586-3
  24. Barnard J, Millner B. A review of topical hemostatic agent for use in cardiac surgery. The Annals of Thoracic Surgery. 2009;88(4):1377-1383. https://doi.org/10.1016/j.athoracsur.2009.02.092
  25. Vescau PJ. Topical hemostatic agents: What the oral and maxillofacial surgeon needs to know. Oral and Maxillofacial Surgery Clinics of North America. 2016;28(4):523-532.  https://doi.org/10.1016/j.coms.201606.007
  26. Bjorses K, Holst J. Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study. European Journal of Vascular and Endovascular Surgery. 2007;33(3):363-370.  https://doi.org/10.1016/j.ejvs.2006.10.011
  27. Shjoldager BTGB, Mikkelsen E, Lykke M, Praest J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldberg N. Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. American Journal of Obstetrics and Gynecology. 2017;216(6):608.e1-608.e5.  https://doi.org/10.1016/j.ajog.2017.02.024
  28. Grochova M, Kalnasova B, Firment J, Olejarova I, Roland R, Lazutova I. Pulmonary administration of activated recombinant factor VII. Bratislavske Lekarske Listy. 2011;112(1):29-33. 
  29. Heslet L, Nielsen JD, Lewi M, Sengelow H, Johansson PI. Sucessful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Critical Care. 2006;10(6):R177. https://doi.org/10.1186/cc5132
  30. Heslet L, Nielsen JD, Nepper-Christensen S. Local pulmonary administration of factor VIIa in diffuse alveolar hemorrhage (DAH) — a review of a new treatment paradigm. Biologics: Targets and Therapy. 2012;6:37-46.  https://doi.org/10.2147/BTT.S25507
  31. Estella A, Jareno A, Fontana LPB. Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrrhage: a report of two case stories. Cases Journal. 2008;1(1):150.  https://doi.org/10.1186/1757-1626-1-150
  32. Park JA, Kim BJ. Intrapulmonary recombinant factor VIIa for diffuse alveolar hemorrhage in children. Pediatrics. 2015;135(1):216-220.  https://doi.org/10.1542/peds.2014-1782
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.